Get started
Author

Yago Pico de Coaña

Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms
2013 · Yumeng Mao, Isabel Poschke, et al. · Cancer Research · 197
Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system
2015 · Yago Pico de Coaña, Aniruddha Choudhury, et al. · Trends in Molecular Medicine · 190
Counteracting CAR T cell dysfunction
2020 · Mansour Poorebrahim, Jeroen Melief, et al. · Oncogene · 175
PDF
Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
2013 · Yago Pico de Coaña, Isabel Poschke, et al. · Cancer Immunology Research · 142
PDF
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
2017 · Yago Pico de Coaña, Maria Wolodarski, et al. · Oncotarget · 139
In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma
2020 · Haris Babačić, Janne Lehtiö, et al. · Journal for ImmunoTherapy of Cancer · 74
IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients
2016 · Rossana Tallerico, Costanza M. Cristiani, et al. · OncoImmunology · 71
PDF
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
2024 · Jean-Luc Van Laethem, Ivan Borbath, et al. · The Lancet Oncology · 67
Interactions among myeloid regulatory cells in cancer
2018 · Viktor Umansky, Gosse J. Adema, et al. · Cancer Immunology Immunotherapy · 63
Self-Delivering RNAi Targeting PD-1 Improves Tumor-Specific T Cell Functionality for Adoptive Cell Therapy of Malignant Melanoma
2018 · Maarten A. Ligtenberg, Yago Pico de Coaña, et al. · Molecular Therapy · 54
PDF
PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates
2020 · Yago Pico de Coaña, Maria Wolodarski, et al. · OncoImmunology · 47
A highly infective Plasmodium vivax strain adapted to Aotus monkeys: Quantitative haematological and molecular determinations useful for P. vivax malaria vaccine development
2003 · Yago Pico de Coaña, Josefa Rodrı&#x;guez, et al. · Vaccine · 42
Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy
2014 · Yago Pico de Coaña, Giuseppe Masucci, et al. · Cancer Immunology Immunotherapy · 36
Molecular cloning and characterization of Cup a 4, a new allergen from Cupressus arizonica
2010 · Yago Pico de Coaña, Nuria Parody, et al. · Biochemical and Biophysical Research Communications · 27
Predicting anti-PD-1 responders in malignant melanoma from the frequency of S100A9+ monocytes in the blood
2021 · Soudabeh Rad Pour, Yago Pico de Coaña, et al. · Journal for ImmunoTherapy of Cancer · 26
PDF
Melanoma and immunotherapy bridge 2015: Naples, Italy. 1–5 December 2015
2016 · Vashisht G. Y. Nanda, Weiyi Peng, et al. · Journal of Translational Medicine · 23
PDF
CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1
2025 · Jean-Luc Van Laethem, Karen Geboes, et al. · Cell Reports Medicine · 11
A Modified Protocol for RNA Isolation from High Polysaccharide Containing Cupressus arizonica Pollen. Applications for RT–PCR and Phage Display Library Construction
2009 · Yago Pico de Coaña, Nuria Parody, et al. · Molecular Biotechnology · 10
High expression of ID1 in monocytes is strongly associated with phenotypic and functional MDSC markers in advanced melanoma
2020 · Jeroen Melief, Yago Pico de Coaña, et al. · Cancer Immunology Immunotherapy · 9
PDF
Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody
2023 · Hampus Andersson, Aastha Sobti, et al. · Cells · 8
PDF
Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Flow Cytometry
2019 · Irene van der Haar Àvila, Patricia Marmol, et al. · Methods in molecular biology · 7
Evaluating Antibody-Dependent Cell-Mediated Cytotoxicity by Chromium Release Assay
2019 · Irene van der Haar Àvila, Patricia Marmol, et al. · Methods in molecular biology · 7
Efficacy and safety of mitazalimab in combination with mFOLFIRINOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): An interim analysis of the optimize-1 phase 1b/2 study.
2023 · Hans Prenen, Ivan Borbath, et al. · Journal of Clinical Oncology · 6
Assessment of Antitumor T-Cell Responses by Flow Cytometry After Coculture of Tumor Cells with Autologous Tumor-Infiltrating Lymphocytes
2019 · Jeroen Melief, Stina Wickström, et al. · Methods in molecular biology · 5
Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation
2015 · Yago Pico de Coaña, Maria Wolodarski, et al. · Journal of Translational Medicine · 5
PDF
Works count: 93
Citation count: 1,474
H-index: 16
I10-index: 18
Year
Topic
Type